Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. 2003

Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont., Canada M5G 1X5.

Human kallikrein 6 (hK6) is a trypsin-like serine protease, member of the human kallikrein gene family. Studies suggested a potential involvement of hK6 in the development and progression of Alzheimer's disease. The serum levels of hK6 might be used as a biomarker for ovarian cancer. To gain insights into the physiological role of this enzyme, we sought to determine its substrate specificity and its interactions with various inhibitors. We produced the proform of hK6 and showed that this enzyme was able to autoactivate, as well as proteolyse itself, leading to inactivation. Kinetic studies indicated that hK6 cleaved with much higher efficiency after Arg than Lys and with a preference for Ser or Pro in the P2 position. The efficient degradation of fibrinogen and collagen types I and IV by hK6 indicated that this kallikrein might play a role in tissue remodeling and/or tumor invasion and metastasis. We also demonstrated proteolysis of amyloid precursor protein by hK6 and determined the cleavage sites at the N-terminal end of the protein. Inhibition of hK6 was achieved via binding to different serpins, among which antithrombin III was the most efficient.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid

Related Publications

Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
June 1999, European journal of biochemistry,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
January 1985, Hypertension (Dallas, Tex. : 1979),
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
February 2006, The Journal of biological chemistry,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
August 2008, Biological chemistry,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
November 1973, Archives of biochemistry and biophysics,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
January 1979, Advances in experimental medicine and biology,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
June 2006, Biological chemistry,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
August 2007, Zoological science,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
June 2002, European journal of biochemistry,
Angeliki Magklara, and Ali A Mellati, and Gregory A Wasney, and Sheila P Little, and Georgia Sotiropoulou, and Gerald W Becker, and Eleftherios P Diamandis
November 2002, Gastroenterology,
Copied contents to your clipboard!